跳至主要内容
临床试验/EUCTR2017-002707-10-DK
EUCTR2017-002707-10-DK进行中(未招募)1 期

Serum-monitoring of anti-dementia drugs, and the relevance to side-effects, clinical efficacy and compliance

Regional Dementia Research Centre, Dept of Neurology0 个研究点目标入组 110 人开始时间: 2017年11月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Dementia in Alzheimers Disease, Parkinsons Disease and Dementia with Lewy Bodies in treatment with either donepezil or memantin
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 90

排除标准

  • Patients without relatives, or living alone. Patients with no ablility to cooperrate. Patients not able to give consent. Patients with primary psychiatric condition. Patients with other medical or neurological conditions which may by themselves explain dementia symptoms. Patients treated with anti-psychotics during past 3 months. Patients with alcohol or drug abuse. Patients receiving ECT within past 3 months. Anaestesia within past 3 months.

研究者

发起方
Regional Dementia Research Centre, Dept of Neurology

相似试验